238 related articles for article (PubMed ID: 9717954)
21. Tamoxifen and the uterus and endometrium.
Cano A; Matallin P; Legua V; Tortajada M; Bonilla-Musoles F
Lancet; 1989 Feb; 1(8634):376. PubMed ID: 18446930
[No Abstract] [Full Text] [Related]
22. Tamoxifen-induced fatty liver in patients with breast cancer.
Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
[No Abstract] [Full Text] [Related]
23. Breast Cancer Prevention Trial shows major benefit, some risk.
Smigel K
J Natl Cancer Inst; 1998 May; 90(9):647-8. PubMed ID: 9586658
[No Abstract] [Full Text] [Related]
24. Anti-estrogens come of age: a pioneer looks back.
Nelson NJ
J Natl Cancer Inst; 1998 May; 90(9):646-7. PubMed ID: 9586657
[No Abstract] [Full Text] [Related]
25. Endoxifen shows promise in breast cancer.
Cancer Discov; 2014 Feb; 4(2):OF1. PubMed ID: 24501306
[TBL] [Abstract][Full Text] [Related]
26. Bilateral swollen eyelids occurring during adjuvant treatment with tamoxifen for early breast cancer.
Jaspers H; Blaisse R; Maessen-Visch B; Mattijssen V
Neth J Med; 2009 Jun; 67(6):245-6. PubMed ID: 19749398
[No Abstract] [Full Text] [Related]
27. Breast cancer biology blossoms in the clinic.
Nass SJ; Hahm HA; Davidson NE
Nat Med; 1998 Jul; 4(7):761-2. PubMed ID: 9662357
[No Abstract] [Full Text] [Related]
28. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs.
Yang G; Nowsheen S; Aziz K; Georgakilas AG
Pharmacol Ther; 2013 Sep; 139(3):392-404. PubMed ID: 23711794
[TBL] [Abstract][Full Text] [Related]
29. [Is there a basis for prevention of breast cancer with drugs?].
Klemetsdal B
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1493-5. PubMed ID: 9198929
[TBL] [Abstract][Full Text] [Related]
30. Endocrine therapy in breast cancer.
Johnson AE
Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602017
[No Abstract] [Full Text] [Related]
31. Tamoxifen for the prevention of breast cancer.
Greenspan EM
Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
[No Abstract] [Full Text] [Related]
32. Tamoxifen in early breast cancer.
Arriagada R
Lancet; 1998 Aug; 352(9125):403-4. PubMed ID: 9717953
[No Abstract] [Full Text] [Related]
33. Talking about tamoxifen.
Goodare H
Health Expect; 2006 Mar; 9(1):91. PubMed ID: 16436165
[No Abstract] [Full Text] [Related]
34. Tamoxifen in early breast cancer.
Benson JR
Lancet; 1998 Aug; 352(9125):404-5. PubMed ID: 9717955
[No Abstract] [Full Text] [Related]
35. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
36. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
Santen RJ
J Clin Endocrinol Metab; 2011 Feb; 96(2):308-19. PubMed ID: 21147884
[TBL] [Abstract][Full Text] [Related]
37. The role of aromatase inhibitor (AI) in the treatment of breast cancer.
Irawan C; Abdulmuthalib
Acta Med Indones; 2005; 37(1):43-8. PubMed ID: 15879638
[No Abstract] [Full Text] [Related]
38. Tamoxifen for breast cancer.
Karn A; Jha AK; Shrestha S; Acharya B; Poudel S; Bhandari RB
JNMA J Nepal Med Assoc; 2010; 49(177):62-7. PubMed ID: 21180225
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen-induced transient multifocal hepatic fatty infiltration.
Cai Q; Bensen M; Greene R; Kirchner J
Am J Gastroenterol; 2000 Jan; 95(1):277-9. PubMed ID: 10638597
[TBL] [Abstract][Full Text] [Related]
40. Adherence rates and correlates in long-term hormonal therapy.
Dunn J; Gotay C
Vitam Horm; 2013; 93():353-75. PubMed ID: 23810015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
